» Articles » PMID: 15502131

Characterization of a First-pass Gradient-echo Spin-echo Method to Predict Brain Tumor Grade and Angiogenesis

Overview
Specialty Neurology
Date 2004 Oct 27
PMID 15502131
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: No widespread clinical method provides specific information about the angiogenic characteristics of gliomas. We characterized blood volume and vascular morphologic parameters from combined gradient-echo (GE) and spin-echo (SE) MR imaging and assessed their relationship to tumor grade, a known correlate of glioma angiogenesis.

Methods: Simultaneous GE and SE echo-planar imaging was performed with bolus gadolinium administration (0.20-0.25 mmol/kg) in 73 patients with glioma. To diminish possible T1 changes due to contrast agent extravasation, a preload (0.05-0.10 mmol/kg) was administered before the study, and a postprocessing correction algorithm was applied. Image maps of total (GE) and microvascular (SE) relative cerebral blood volume (rCBV) and the mean vessel diameter (mVD) calculated from the ratio of GE and SE relaxation rate changes (DeltaR2*/DeltaR2) were compared with tumor grade. A nonparametric K nearest-neighbor decision rule was applied to determine if the combined data could be used to distinguish low-grade (I-II) from high-grade (III-IV) tumors on a per-patient basis.

Results: For whole tumors, significant correlations were found between GE rCBV and grade (P < .0001) and between mVD and grade (P = .0001) but not between SE rCBV and grade (P = .08). For areas of highest SE rCBV (microvascular hotspots), SE rCBV and tumor grade were significantly correlated (P = .0007). In terms of differentiation, 69% of low-grade tumors and 96% of high-grade tumors were correctly classified.

Conclusion: Combined GE and SE MR imaging provides information consistent with neoplastic angiogenesis, demonstrating its potential to aid in optimizing treatments, categorizing lesions, and influencing patient care.

Citing Articles

Susceptibility-Weighted MRI for Predicting NF-2 Mutations and S100 Protein Expression in Meningiomas.

Azamat S, Buz-Yalug B, Dindar S, Yilmaz Tan K, Ozcan A, Can O Diagnostics (Basel). 2024; 14(7).

PMID: 38611661 PMC: 11012050. DOI: 10.3390/diagnostics14070748.


Practical guidance to identify and troubleshoot suboptimal DSC-MRI results.

Prah M, Schmainda K Front Radiol. 2024; 4:1307586.

PMID: 38445104 PMC: 10913595. DOI: 10.3389/fradi.2024.1307586.


A cross-sectional study to test equivalence of low- versus intermediate-flip angle dynamic susceptibility contrast MRI measures of relative cerebral blood volume in patients with high-grade gliomas at 1.5 Tesla field strength.

Shiroishi M, Weinert D, Cen S, Varghese B, Dondlinger T, Prah M Front Oncol. 2023; 13:1156843.

PMID: 37799462 PMC: 10548232. DOI: 10.3389/fonc.2023.1156843.


Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures.

Hu L, DAngelo F, Weiskittel T, Caruso F, Fortin Ensign S, Blomquist M Nat Commun. 2023; 14(1):6066.

PMID: 37770427 PMC: 10539500. DOI: 10.1038/s41467-023-41559-1.


Advanced MRI Protocols to Discriminate Glioma From Treatment Effects: State of the Art and Future Directions.

Malik D, Rath T, Urcuyo Acevedo J, Canoll P, Swanson K, Boxerman J Front Radiol. 2023; 2:809373.

PMID: 37492687 PMC: 10365126. DOI: 10.3389/fradi.2022.809373.


References
1.
Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K . Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology. 1993; 189(1):233-8. DOI: 10.1148/radiology.189.1.8372199. View

2.
Plate K, Mennel H . Vascular morphology and angiogenesis in glial tumors. Exp Toxicol Pathol. 1995; 47(2-3):89-94. DOI: 10.1016/S0940-2993(11)80292-7. View

3.
Bernsen H, Rijken P, Peters J, BAKKER J, Boerman R, Wesseling P . Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status. J Neurooncol. 2000; 44(2):129-36. DOI: 10.1023/a:1006363215260. View

4.
Boxerman J, Rosen B, Weisskoff R . Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies. J Magn Reson Imaging. 1997; 7(3):528-37. DOI: 10.1002/jmri.1880070313. View

5.
Hou L, Yang Y, Mattay V, Frank J, Duyn J . Optimization of fast acquisition methods for whole-brain relative cerebral blood volume (rCBV) mapping with susceptibility contrast agents. J Magn Reson Imaging. 1999; 9(2):233-9. DOI: 10.1002/(sici)1522-2586(199902)9:2<233::aid-jmri13>3.0.co;2-v. View